About Magellan BioScience Group
Magellan BioScience Group is a Healthcare company based in Tampa (United States) founded in 1997, and was acquired by Meridian Bioscience in March 2016. Identifies and develops microbial natural product leads for pharmaceutical and industrial applications. Magellan BioScience Group has completed 1 acquisition, including TREK Diagnostic Systems. Magellan BioScience Group offers products and services including Microbial Strains Library and Pure Peptide Library. Its focus areas include Biopharma Outsourcing, CRO, Drug Discovery and Natural Products. Its legal entity is Magellan Bioscience Group Inc.
Company details
Founded in 1997 and based in Tampa, United States, Magellan BioScience Group operates in the biotechnology sector, focusing on microbial natural products. Research libraries with diverse compounds are offered for applications in pharmaceuticals, agrochemicals, specialty chemicals, and animal health care. Services such as microbial biotransformation, synthetic modifications, and structure elucidation are provided, along with separation and spectroscopic analysis. Partnerships have been established with organizations including BioFlorida, AndroBioSys, and Kemin Pharmaceuticals.
- Headquarters Tampa, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website magellanbioscience.com
- Social LinkedIn X Facebook
- Acquired by Meridian Bioscience (Mar 2016)
- Legal Name Magellan Bioscience Group Inc
- Latest Funding Round$25K (USD), Unspecified
Sep 2012
- InvestorsMeridian Bioscience
& 2 more
- Investments & Acquisitions
- Acquired byMeridian Bioscience
(Mar 2016)
Products & Services of Magellan BioScience Group
Magellan BioScience Group offers a comprehensive portfolio of products and services, including Microbial Strains Library and Pure Peptide Library.
Collection of over 10,000 microbial strains for drug discovery studies.
Over 2400 pure peptides for high-throughput screening assays.
Funding Insights of Magellan BioScience Group
- Total Rounds 2
- Last Round Unspecified — $25,000
- First Round $350,000
(Jul 2007)
- Investors Count 2
All 2 funding rounds of Magellan BioScience Group with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2012 | $25,000 | Unspecified | – | – | – |
| Jul 2007 | $350,000 | Grant | – | – |
3 investors in total: 3 institutional.
Investors in Magellan BioScience Group
Magellan BioScience Group has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Meridian Bioscience, NIH and Florida High Tech Corridor.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Drug discovery services are provided to the biopharma sector. | 1887 | nih.gov | United States | |
The Florida High Tech Corridor is focused on regional high-tech development. | floridahightech.com | United States | ||
Molecular diagnostic device and kits | 1976 | meridianbioscience.com | Ohio, United States |
Investor details for Magellan BioScience Group
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Magellan BioScience Group
Magellan BioScience Group has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include TREK Diagnostic Systems.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Offers microbiology solution | trekds.com | Cleveland, United States | 1999 | Nov 2006 | •••• |
Complete acquisition details for Magellan BioScience Group
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Magellan BioScience Group
5 dated milestones of Magellan BioScience Group across 19 years, from founding to its latest funding, stage changes and deals.
- Founded Magellan BioScience Group is founded.
- Acquisition Acquires TREK Diagnostic Systems.
- Funding First funding round of $350K.
- Funding Latest funding round, Unspecified, of $25K.
- Exit Acquired by Meridian Bioscience.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Magellan BioScience Group (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Magellan BioScience Group
Magellan BioScience Group was founded in 1997 and raised its 1st funding round 10 years after it was founded.
Magellan BioScience Group is headquartered in Tampa, United States. It is registered at Tampa, Florida, United States.
Founded in 1997 and based in Tampa, United States, Magellan BioScience Group operates in the biotechnology sector, focusing on microbial natural products. Research libraries with diverse compounds are offered for applications in pharmaceuticals, agrochemicals, specialty chemicals, and animal health care. Services such as microbial biotransformation, synthetic modifications, and structure elucidation are provided, along with separation and spectroscopic analysis. Partnerships have been established with organizations including BioFlorida, AndroBioSys, and Kemin Pharmaceuticals.
Magellan BioScience Group offers Microbial Strains Library and Pure Peptide Library.
Magellan BioScience Group has made 1 acquisition, including TREK Diagnostic Systems.
Magellan BioScience Group has 3 investors. Key investors include Meridian Bioscience, NIH, and Florida High Tech Corridor.
Magellan BioScience Group operates through Magellan Bioscience Group Inc.
Yes. Magellan BioScience Group was acquired by Meridian Bioscience in March 2016.